Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (411-420 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Substituted Lactams as 5‑HT1A Agonists for Treating Neuropsychiatric DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Pyridine Derivatives as 5‑HT2A Agonists for Treating Psychiatric DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Pyridazine Compounds as NLRP3 Inhibitors for Treating Parkinson's Disease or Frontotemporal DementiaRam W Sabnis
ACS Medicinal Chemistry Letters|March 19, 2025
Novel 1,6-Naphthridine Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II DiabetesRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel KRAS Inhibitors for Treating Non-Small-Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel Heteroaryl Compounds as CD73 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 17, 2023
8-Aza Quinazolines as Brain Penetrant SOS1 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|March 20, 2024
TYK2 Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
Pageof 2,416

Showing results (411-420 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Substituted Lactams as 5‑HT1A Agonists for Treating Neuropsychiatric DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Pyridine Derivatives as 5‑HT2A Agonists for Treating Psychiatric DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Pyridazine Compounds as NLRP3 Inhibitors for Treating Parkinson's Disease or Frontotemporal DementiaRam W Sabnis
ACS Medicinal Chemistry Letters|March 19, 2025
Novel 1,6-Naphthridine Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II DiabetesRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel KRAS Inhibitors for Treating Non-Small-Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel Heteroaryl Compounds as CD73 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 17, 2023
8-Aza Quinazolines as Brain Penetrant SOS1 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|March 20, 2024
TYK2 Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
Pageof 2,416